Long-acting methylphenidate. An alternative medical therapy for adult patients with attention deficit hyperactivity disorder;Retardiertes methylphenidat. Eine alternative in der medikamentösen therapie bei erwachsenen patienten mit aufmerksamkeitsdefizit-/ hyperaktivitätsstörung

Nervenarzt

Volumn 76, Issue 11, 2005, Pages 1412-1417

  Sobanski, E ^a   Alm, B ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Adult attention deficit hyperactivity disorder; Immediate release methylphenidate; OROS methylphenidate; Pharmacotherapy

Indexed keywords

LONG ACTING DRUG; METHYLPHENIDATE;

ADULT; ATTENTION DEFICIT DISORDER; BODY WEIGHT; CASE REPORT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DYSPHORIA; FEMALE; HUMAN; MENTAL CONCENTRATION; REBOUND; RESTLESSNESS; REVIEW; SYMPTOM;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; METHYLPHENIDATE; TREATMENT OUTCOME;

EID: 28744433710     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-1892-y     Document Type: Review

References (11)

1. Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus. Nervenarzt 74:939-946
2. Spencer TJ, Wilens TE, Biederman J et al. (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 52:434-443
3. Paterson R, Douglas C, Hallmayer J et al. (1999) A randomized, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 33:494-502
4. Spencer TJ, Biederman J, Wilens TE et al. (2001) Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58:775-782
5. Faraone SV, Biederman J, Spencer TJ (2004) Dose-response efficacy of mixed amphetamine salts XR in adults with ADHD. Poster presented at the 157th Annual Meeting of the American Psychiatric Association
6. Wilens TE, Biederman J, Spencer TJ et al. (2001) Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 19:257-264
7. Wolraich ML, Greenhill LL, Pelham W et al. (2001) Randomized, controlled trial of OROS-methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics 108:883-889
8. Brown TE (1996) Brown attention disorder scales manuals. Psychological Corparation, San Antonio
9. Retz-Junginger P, Retz W, Blocher et al. (2003) Reliabilität und Validität der Wender-Utah-Rating-Scale-Kurzform. Nervenarzt 11:987-993
10. Weiss M, Jain U, Garland J (2000) Clinical suggestions for management of stimulant treatment in adolescents. Can J Psychiatry 45:717-723
11. Cox DJ, Merkel RL, Penberthy JK et al. (2004) Impact of methylphenidate delivery profile on driving performance of adolescents with attention-deficit/ hyperactivity disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 43:269-275